Attend Subtle's upcoming webinar to learn more: "Case Study with Green Imaging: Optimizing MRI Efficiency and Patient Care with AI" on Tuesday, March 23rd at 10am PST / 1pm EST.
Subtle Medical has an extensive product pipeline. The company's focus on image acquisition differentiates it from most AI imaging products, which focus on computer-aided diagnosis. Subtle Medical also has FDA cleared and CE marked SubtlePET™, which enables centers to denoise low count PET images acquired in 25% of the original scan time. A third product currently in the investigational phase is SubtleGAD™, a software solution that can reduce gadolinium dose by 90% during imaging procedures while maintaining high quality diagnostic MRI images.
Ad Statistics
Times Displayed: 2147
Times Visited: 10 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
About Subtle Medical
Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that increase the quality and efficiency of medical imaging. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner. Current clinical partners include UCSF, Hoag Hospital, Mount Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners.
SOURCE Subtle Medical
Back to HCB News
